Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Pharma
Apellis' Syfovre faces tough road ahead in GA market: analyst
Despite holding the lead with its complement inhibitor Syfovre, Apellis is discovering that the geographic atrophy market is a tough nut to crack.
Fraiser Kansteiner
May 14, 2025 11:10am
US drug pricing poised to continue trending upward: Cowen report
Jan 9, 2025 8:29am
RFK Jr.'s 'biggest threat' to pharma is possible ad ban: analyst
Nov 25, 2024 10:50am
New CKD drugs are promising, but not yet disruptive: report
Jun 26, 2024 10:45am
ALS market to grow 15% by end of decade: report
Jun 13, 2024 11:20am
Sanofi, GSK and Novo benefit from currency changes: analyst
Oct 21, 2022 9:21am
